US Patent Issued to UMC UTRECHT HOLDING on Jan. 20 for "Treatment of IgE-mediated diseases with antibodies that specifically bind CD38" (Dutch Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,878, issued on Jan. 20, was assigned to UMC UTRECHT HOLDING B.V. (Utrecht, Netherlands).

"Treatment of IgE-mediated diseases with antibodies that specifically bind CD38" was invented by Henny G. Otten (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to treatment of IgE-mediated disease with antibodies that specifically bind CD38."

The patent was filed on June 5, 2023, under Application No. 18/329,443.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&c...